Liquid Biopsy and Early Detection: The Holy Grail of the AI in Cancer Diagnostic Market
For decades, diagnosing cancer definitively required a highly invasive, physical tissue biopsy. This process is inherently traumatic, expensive, and often impossible if the tumor is located deep within an organ like the lung or pancreas. Today, the global oncology sector is aggressively pursuing the "holy grail" of medicine: detecting cancer from a simple blood draw. To overcome the monumental...
0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior
SocioMint https://sociomint.com